PDE4 inhibitors in psoriasis therapy: current insights and future directions

Ahn SC, Kim GY, Kim JH et al (2004) Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-κB. Biochem Biophys Res Commun 313:148–155. https://doi.org/10.1016/J.BBRC.2003.11.108

Article  CAS  PubMed  Google Scholar 

Alanzi AR, Alsalhi MS, Mothana RA et al (2024) Insilico discovery of novel phosphodiesterase 4 (PDE4) inhibitors for the treatment of psoriasis: insights from computer aided drug design approaches. PLoS ONE 19:e0305934. https://doi.org/10.1371/JOURNAL.PONE.0305934

Article  CAS  PubMed  PubMed Central  Google Scholar 

Armstrong AW, Read C (2020) Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323:1945–1960. https://doi.org/10.1001/JAMA.2020.4006

Article  CAS  PubMed  Google Scholar 

Arora S, Das P, Arora G (2021) Systematic review and recommendations to combine newer therapies with conventional therapy in psoriatic disease. Front Med (Lausanne) 8:696597. https://doi.org/10.3389/FMED.2021.696597

Article  PubMed  Google Scholar 

Azevedo MF, Faucz FR, Bimpaki E et al (2014) Clinical and molecular genetics of the phosphodiesterases (PDEs). Endocr Rev 35:195–233. https://doi.org/10.1210/ER.2013-1053

Article  CAS  PubMed  Google Scholar 

Balak DMW, Gerdes S, Parodi A, Salgado-Boquete L (2020) Long-term safety of oral systemic therapies for psoriasis: a comprehensive review of the literature. Dermatol Ther 10(4):589–613. https://doi.org/10.1007/S13555-020-00409-4

Article  Google Scholar 

Barros NDM, Sbroglio LL, Buffara MDO et al (2021) Phototherapy. An Bras Dermatol 96:397–407. https://doi.org/10.1016/J.ABD.2021.03.001

Article  PubMed  PubMed Central  Google Scholar 

Baur JA, Sinclair DA (2006) Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 5(6):493–506. https://doi.org/10.1038/nrd2060

Article  CAS  PubMed  Google Scholar 

Bereswill S, Muñoz M, Fischer A et al (2010) Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS ONE 5:e15099. https://doi.org/10.1371/JOURNAL.PONE.0015099

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bianchi L, Del Duca E, Romanelli M et al (2016) Pharmacodynamic assessment of apremilast for the treatment of moderate-to-severe plaque psoriasis. Expert Opin Drug Metab Toxicol 12:1121–1128. https://doi.org/10.1080/17425255.2016.1206886

Article  CAS  PubMed  Google Scholar 

Biasutto L, Mattarei A, Azzolini M et al (2017) Resveratrol derivatives as a pharmacological tool. Ann N Y Acad Sci 1403:27–37. https://doi.org/10.1111/NYAS.13401

Article  CAS  PubMed  Google Scholar 

Bissonnette R, Haydey R, Rosoph LA et al (2018) Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized study. J Eur Acad Dermatol Venereol 32:403–410. https://doi.org/10.1111/JDV.14647

Article  CAS  PubMed  Google Scholar 

Blauvelt A, Langley RG, Gordon KB et al (2023) Next generation PDE4 inhibitors that selectively target PDE4B/D subtypes: a narrative review. Dermatol Ther (Heidelb) 13:3031. https://doi.org/10.1007/S13555-023-01054-3

Article  PubMed  Google Scholar 

Borgia F, Custurone P, Li Pomi FL et al (2022a) IL-31: state of the art for an inflammation-oriented interleukin. Int J Mol Sci 23:6507. https://doi.org/10.3390/IJMS23126507

Article  CAS  PubMed  PubMed Central  Google Scholar 

Borgia F, Li Pomi F, Vaccaro M et al (2022b) Oxidative stress and phototherapy in atopic dermatitis: mechanisms, role, and future perspectives. Biomolecules 12:1904. https://doi.org/10.3390/BIOM12121904

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bros M, Montermann E, Cholaszczyńska A, Reske-Kunz AB (2016) The phosphodiesterase 4 inhibitor roflumilast augments the Th17-promoting capability of dendritic cells by enhancing IL-23 production, and impairs their T cell stimulatory activity due to elevated IL-10. Int Immunopharmacol 35:174–184. https://doi.org/10.1016/J.INTIMP.2016.03.025

Article  CAS  PubMed  Google Scholar 

Bungau S, Abdel-Daim MM, Tit DM, Ghanem E, Sato S, Maruyama-Inoue M, Yamane S, Kadonosono K (2019) Health benefits of polyphenols and carotenoids in age-related eye diseases. Oxid Med Cell Longevity 2019:1–22

Article  Google Scholar 

Campione E, Cosio T, Pistoia ES et al (2024) Prevalence of fungal colonization among patients with psoriasis in difficult-to-treat areas: impact of apremilast on mycotic burden and clinical outcomes. Front Immunol 15:1508489. https://doi.org/10.3389/FIMMU.2024.1508489/BIBTEX

Article  CAS  PubMed  PubMed Central  Google Scholar 

Caruso G, Godos J, Privitera A et al (2022) Phenolic acids and prevention of cognitive decline: polyphenols with a neuroprotective role in cognitive disorders and Alzheimer’s disease. Nutrients 14:819. https://doi.org/10.3390/NU14040819

Article  CAS  PubMed  PubMed Central  Google Scholar 

Choi J, Kim B, Youn SW (2017) Adherence to topical therapies for the treatment of psoriasis: surveys of physicians and patients. Ann Dermatol 2017(29):5–559

Google Scholar 

Choi JY, Owusu-Ayim M, Dawe R et al (2021) Narrowband ultraviolet B phototherapy is associated with a reduction in topical corticosteroid and clinical improvement in atopic dermatitis: a historical inception cohort study. Clin Exp Dermatol 46:1067–1074. https://doi.org/10.1111/CED.14676

Article  CAS  PubMed  Google Scholar 

Cooney J, Wang L, Lin A-P et al (2016) Synergism between PDE4 and PI3Kδ inhibitors in DLBCL: improved clinical activity with the potential for lower toxicity. Blood 128:2938–2938. https://doi.org/10.1182/BLOOD.V128.22.2938.2938

Article  Google Scholar 

Crowley EL, Gooderham MJ (2023) Phosphodiesterase-4 Inhibition in the Management of Psoriasis. Pharmaceutics 16:23. https://doi.org/10.3390/PHARMACEUTICS16010023

Article  PubMed  PubMed Central  Google Scholar 

Dainichi T, Hanakawa S, Kabashima K (2014) Classification of inflammatory skin diseases: a proposal based on the disorders of the three-layered defense systems, barrier, innate immunity and acquired immunity. J Dermatol Sci 76:81–89. https://doi.org/10.1016/J.JDERMSCI.2014.08.010

Article  PubMed  Google Scholar 

Danesh MJ, Beroukhim K, Nguyen C et al (2015) Apremilast and adalimumab: a novel combination therapy for recalcitrant psoriasis. Dermatol Online J 21:6. https://doi.org/10.5070/D3216027825

Article  Google Scholar 

De A, Das S, Dhoot D, Sarda A (2019) Apremilast coadministered with secukinumab for safe and effective control of psoriasis with resultant reduction of maintenance dose of the biologic. Indian J Dermatol 64:239. https://doi.org/10.4103/IJD.IJD_548_18

Article  PubMed  PubMed Central  Google Scholar 

de Brito Oliveira AL, Monteiro VVS, Navegantes-Lima KC et al (2017) Resveratrol role in autoimmune disease—a mini-review. Nutrients 29:1306. https://doi.org/10.3390/NU9121306

Article  Google Scholar 

de Lima Cherubim DJ, Buzanello Martins CV, Oliveira Fariña L, da Silva de Lucca RA (2020) Polyphenols as natural antioxidants in cosmetics applications. J Cosmet Dermatol 19:33–37. https://doi.org/10.1111/JOCD.13093

Article  PubMed  Google Scholar 

Di Salvo E, Gangemi S, Genovese C et al (2023) Polyphenols from Mediterranean plants: biological activities for skin photoprotection in atopic dermatitis, psoriasis, and chronic urticaria. Plants 12:3579. https://doi.org/10.3390/PLANTS12203579

Article  PubMed  PubMed Central  Google Scholar 

Dvorakova M, Landa P (2017) Anti-inflammatory activity of natural stilbenoids: a review. Pharmacol Res 124:126–145. https://doi.org/10.1016/J.PHRS.2017.08.002

Article  CAS 

Comments (0)

No login
gif